Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Need For At-Home Blood Pressure Monitoring Underscored By High-Profile Cardiac Deaths
Heart disease is the leading cause of death in men in the United States(1). Yet it"s often not until the untimely passing of a celebrity from a cardiac event - such as Billy Mays or Tim Russert - that the issue is brought to the forefront of Americans" health and wellness routine. And even then, when there"s a heightened focus on heart health, a recent survey(2) uncovered that only 14 percent of people would be inclined to start regularly monitoring their blood pressure at home - a preventive measure highly recommended by the American Heart Association (AHA)(3) since it can help signal impending cardiac distress caused by high blood pressure.

Study Finds Noninvasive Blood Test For Liver Fibrosis May Alleviate Need For Liver Biopsies For Some Patients With Chronic Hepatitis C
A study in the June issue of Clinical Gastroenterology and Hepatology, published by Elsevier, demonstrates that the Hepascore(TM) liver fibrosis blood-serum test panel may help physicians more accurately diagnose and stage liver fibrosis in patients with chronic hepatitis C (HCV), potentially alleviating the need for liver biopsy, the standard of care for staging fibrosis, in a particular subset of patients. The Hepascore test panel is provided exclusively by Quest Diagnostics Incorporated (NYSE: DGX), the world"s leading provider of diagnostic testing, information and services.
News of the day
Newborn Brain Cells Show The Way
Although the fact that we generate new brain cells throughout life is no longer disputed, their purpose has been the topic of much debate. Now, an international collaboration of researchers made a big leap forward in understanding what all these newborn neurons might actually do. Their study, published in the July 10, 2009, issue of the journal Science, illustrates how these young cells improve our ability to navigate our environment.
Oncology

Comprehensive Review On Sulfonylureas In The Latest Issue Of Diabetic Hypoglycemia (09 June 2009)

The latest issue of the online journal Diabetic Hypoglycemia features an authoritative review on sulfonylureas by Professor Ian Campbell, a leading expert in oral hypoglycemia therapy. Professor Campbell"s review focuses on sulfonylurea-induced hypoglycemia (SIH), which is a well-recognized side-effect of this class of therapy for type 2 diabetes. In the review he discusses the incidence of SIH, with particular reference to the different sulfonylureas. He also reflects on the morbidity and mortality seen with SIH, precipitating risk factors, treatment of SIH, and education of patients and medical staff in the prevention of SIH. This issue of Diabetic Hypoglycemia also includes a case study on recurring hypoglycemia associated with glibenclamide, by Professor Campbell. Dr Rory McCrimmon of the Editorial Board reviews the literature on blood glucose monitoring in hypoglycemia, in an editorial entitled "What we"re learning from continuous glucose monitoring". This issue of Diabetic Hypoglycemia also features an "In profile" interview with Professor Stephanie Amiel, a leading expert in the use of neuroimaging in diabetes and hypoglycemia. About the Journal Diabetic Hypoglycemia is an influential online diabetes journal. The Editorial Board of hypoglycemia experts peer review all Journal content. The Board is led by Editor-in-Chief Professor Brian Frier (Edinburgh, UK), with Associate Editors: Professor Simon Heller (Sheffield, UK), Professor Christopher Ryan (Pittsburgh, USA) and Dr Rory McCrimmon (Yale, USA). Diabetic Hypoglycemia is published three times a year, providing an interactive forum for readers to share practical knowledge and opinions on the rapidly evolving field of hypoglycemia. To explore the Diabetic Hypoglycemia website and its key features, our guided tour can be activated by clicking the following link here. Diabetic Hypoglycemia is published by ESP Bioscience. Support for the journal is provided by an unrestricted educational grant from Novo Nordisk A/S (Bagsvaerd, Denmark). ESP Bioscience


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009